A DEB, also known as a drug-coated balloon (DCB), is an advanced technology used in the treatment of coronary and peripheral arterial diseases. These diseases cause narrowing of arteries leading to blockages. A DEB is used along with paclitaxel, an anti-proliferative drug, which helps in removing plaque from the walls of arteries and widening them. DEBs are primarily used in the treatment of two types of diseases: Peripheral arterial diseases (PADs), and Coronary arterial diseases (CADs).
Open heart surgeries and open peripheral surgeries can be life-threating as they involve several complications. This is compelling surgeons to adopt MI techniques over traditional techniques since they ensure high accuracy, faster recovery, fewer post-surgery infections, reduced hospital stays and incision marks, and minimal complications. This will increase the demand for DEBs since they enhance surgical precision by providing a 3D view of the patient and allows the insertion of DEBs in an individual's body by enabling the manipulation of small surgical tools.
The DEBs market is characterized by the presence of several players. Vendors are coming up with various advanced technologies such as IN.PACT Admiral, Lutonix 035, SeQuent Please Neo, Elutax SV, Freeway, Advance 18 PTX and DIOR. This will drive the demand for DEBs and increase the sales volume and profit margins of vendors. The availability of a substantial number of CE approved DEB products, an increase in the number of clinical trials, and the approval of certain DEB products by the US FDA, will offer significant growth opportunities to the vendors.
The global Drug Eluting Balloons (DEBs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drug Eluting Balloons (DEBs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug Eluting Balloons (DEBs) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Drug Eluting Balloons (DEBs) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Drug Eluting Balloons (DEBs) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
B. Braun Melsungen
Cook Medical
C.R. Bard
Eurocor
Medtronic
Aachen Resonance
Acrostak
Cardionovum
Spectranetics
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Peripheral DEBs
Coronary DEBs
Segment by Application
Cath labs
Hospitals
Ambulatory surgical centers (ASCs)
Summary:
Get latest Market Research Reports on Drug Eluting Balloons (DEBs). Industry analysis & Market Report on Drug Eluting Balloons (DEBs) is a syndicated market report, published as Global Drug Eluting Balloons (DEBs) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Drug Eluting Balloons (DEBs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.